Clinical Trials Logo
NCT number NCT00000102
Study type Interventional
Source National Center for Research Resources (NCRR)
Contact
Status Completed
Phase Phase 1/Phase 2

Clinical Trial Summary

This study will test the ability of extended release nifedipine (Procardia XL), a blood pressure medication, to permit a decrease in the dose of glucocorticoid medication children take to treat congenital adrenal hyperplasia (CAH).


Clinical Trial Description

This protocol is designed to assess both acute and chronic effects of the calcium channel antagonist, nifedipine, on the hypothalamic-pituitary-adrenal axis in patients with congenital adrenal hyperplasia. The multicenter trial is composed of two phases and will involve a double-blind, placebo-controlled parallel design. The goal of Phase I is to examine the ability of nifedipine vs. placebo to decrease adrenocorticotropic hormone (ACTH) levels, as well as to begin to assess the dose-dependency of nifedipine effects. The goal of Phase II is to evaluate the long-term effects of nifedipine; that is, can attenuation of ACTH release by nifedipine permit a decrease in the dosage of glucocorticoid needed to suppress the HPA axis? Such a decrease would, in turn, reduce the deleterious effects of glucocorticoid treatment in CAH.


Study Design

Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


See also
  Status Clinical Trial Phase
Recruiting NCT03162159 - Adult Height Prediction in Congenital Adrenal Hyperplasia N/A
Recruiting NCT02795871 - Prenatal Dex Study N/A
Not yet recruiting NCT02934399 - Dynamic Hormone Diagnostics in Endocrine Disease Phase 2/Phase 3
Active, not recruiting NCT02804178 - A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia Phase 2
Completed NCT01807364 - Cardiovascular Risk Profile in Patients With Congenital Adrenal Hyperplasia N/A
Completed NCT03019614 - An Open Label Study in Healthy Volunteers to Compare Chronocort® to Hydrocortisone Phase 1
Active, not recruiting NCT01875640 - Decision Support for Parents Receiving Information About Child's Rare Disease N/A
Withdrawn NCT00485186 - Gene Polymorphisms Influencing Steroid Synthesis and Action N/A
Recruiting NCT03257462 - Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia Phase 2
Completed NCT00559078 - Qualitative Research on Women With Congenital Adrenal Hyperplasia N/A
Recruiting NCT02716818 - Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia Phase 3
Completed NCT00011791 - Catecholamine Reserve and Exercise Tolerance in Healthy Volunteers and Patients With Congenital Adrenal Hyperplasia N/A
Withdrawn NCT02349503 - Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia Phase 1
Completed NCT03051893 - A Two-part, Study to Compare the Pharmacokinetics and Dose Proportionality of up to 6 Chronocort Formulations Phase 1
Completed NCT00001521 - Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia Phase 1
Completed NCT01735617 - Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH Phase 2
Recruiting NCT02552251 - COrticosteroid in Congenital Adrenal Hyperplasia Phase 2/Phase 3
Recruiting NCT01184651 - Tweens to Teens Project at Penn State N/A
Completed NCT00519818 - Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia Phase 1/Phase 2
Recruiting NCT00172510 - Mutation Analysis of 17α-Hydroxylase N/A